Financhill
Back

GDS Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
29

GDS
GDS Holdings

Last Price:
$19.84
Seasonality Move:
19.93%
Buy
54

SRPT
Sarepta Therapeutics

Last Price:
$53.93
Seasonality Move:
12.51%
Sell
29
GDS Holdings (GDS) is a Sell

Is GDS Holdings a Buy, Sell or Hold?

  • The current GDS Holdings [GDS] share price is $20.63. The Score for GDS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • GDS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $54.42. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GDS Stock Price Chart

What is GDS Holdings's stock price today?

  • The GDS Holdings share price today is $20.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDS is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $54.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

GDS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.28 Sell
Relative Strength Index (14 RSI): 35.39 Sell
Chaikin Money Flow: 493471 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.12 Sell
Relative Strength Index (14 RSI): 31.94 Sell
Chaikin Money Flow: -520094 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

GDS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.16 Buy
20-day SMA: 24.18 Sell
50-day SMA: 30.76 Sell
200-day SMA: 21.26 Sell
8-day EMA: 21.08 Sell
20-day EMA: 24.22 Sell
50-day EMA: 27.14 Sell
200-day EMA: 22.38 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.77 Buy
20-day SMA: 63.08 Sell
50-day SMA: 88.76 Sell
200-day SMA: 119.57 Sell
8-day EMA: 54.88 Sell
20-day EMA: 64.14 Sell
50-day EMA: 82.53 Sell
200-day EMA: 109.32 Sell

GDS Holdings Earnings Growth & GDS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and an increase next year of $0.43 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.

GDS Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):